Last Week in AI

Latest Episodes:

Catalyzing AI Innovation: AI21 Labs Secures $155M for Enterprise Generative AI Mar 23, 2024

Show notes

In this episode, we explore how AI21 Labs' recent $155 million funding round is poised to catalyze innovation in the field of enterprise generative AI, discussing the potential impact of this investment on businesses and industries worldwide.

Invest in AI Box: https://Republic.com/ai-box
Get on the AI Box Waitlist: ⁠⁠https://AIBox.ai/⁠⁠
AI Facebook Community
Learn more about AI in Music
Learn more about AI Models

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Transforming Education: OpenAI's Custom ChatGPT for Teachers Mar 23, 2024

Show notes

In this episode, we delve into the transformative potential of OpenAI's personalized ChatGPT prompts for educators, discussing its implications for curriculum design and student-centered learning approaches.

Invest in AI Box: https://Republic.com/ai-box
Get on the AI Box Waitlist: ⁠⁠https://AIBox.ai/⁠⁠
AI Facebook Community
Learn more about AI in Music
Learn more about AI Models

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

AI's Impact on Business Analytics: Perspectives from Chata.ai CEO Kelly Cherniwchan Mar 22, 2024

Show notes

In this episode, we explore AI's transformative impact on business analytics with insights from Kelly Cherniwchan, CEO of Chata.ai, discussing how AI is revolutionizing data analysis and empowering organizations to drive growth and innovation.

Invest in AI Box: https://Republic.com/ai-box
Get on the AI Box Waitlist: ⁠⁠https://AIBox.ai/⁠⁠
AI Facebook Community
Learn more about AI in Music
Learn more about AI Models

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Export Control Policy: U.S. Curbs Nvidia, AMD AI Chip Sales to Middle East Mar 22, 2024

Show notes

In this episode, we examine the intricacies of export control policy as the U.S. restricts the sale of AI chips by Nvidia and AMD to the Middle East, analyzing the potential impacts on technology access, market competition, and international relations.

Invest in AI Box: https://Republic.com/ai-box
Get on the AI Box Waitlist: ⁠⁠https://AIBox.ai/⁠⁠
AI Facebook Community
Learn more about AI in Music
Learn more about AI Models

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

AI Chronicles: Baidu's Innovations, IBM Collaborates with Salesforce, .ai's Funding Milestone Mar 22, 2024

Show notes

In this episode, we chronicle the latest AI advancements, highlighting Baidu's innovative projects, IBM's collaboration with Salesforce, and .ai's milestone funding achievement.

Invest in AI Box: https://Republic.com/ai-box
Get on the AI Box Waitlist: ⁠⁠https://AIBox.ai/⁠⁠
AI Facebook Community
Learn more about AI in Music
Learn more about AI Models

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Innovating PR: Paula Phelan, COO of Intelligent Relations, on AI's Role in Shaping the Future Mar 22, 2024

Show notes

In this episode, we sit down with Paula Phelan, COO of Intelligent Relations, to explore the evolving landscape of public relations (PR) in the digital age, discussing the strategic advantages of integrating AI technologies in reputation management, crisis communication, and brand storytelling.

Invest in AI Box: https://Republic.com/ai-box
Get on the AI Box Waitlist: ⁠⁠https://AIBox.ai/⁠⁠
AI Facebook Community
Learn more about AI in Music
Learn more about AI Models

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Catalyzing Change: QuantHealth's $15M Investment for AI-Driven US Clinical Drug Trials Mar 22, 2024

Show notes

In this episode, we discuss the transformative potential of QuantHealth's recent $15 million funding round in catalyzing advancements in US clinical drug trials through AI integration, and the broader implications for enhancing the efficiency and effectiveness of healthcare research.

Invest in AI Box: https://Republic.com/ai-box
Get on the AI Box Waitlist: ⁠⁠https://AIBox.ai/⁠⁠
AI Facebook Community
Learn more about AI in Music
Learn more about AI Models

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Ensuring Respect: Call of Duty and Modulate's AI Solution for Voice Chat Etiquette 🌶️ Mar 22, 2024

Show notes

In this episode, we discuss how Call of Duty and Modulate are employing AI technology to promote respectful communication in voice chat, analyzing the effectiveness of automated moderation tools in mitigating toxic behavior within online gaming environments.

Invest in AI Box: https://Republic.com/ai-box
Get on the AI Box Waitlist: ⁠⁠https://AIBox.ai/⁠⁠
AI Facebook Community
Learn more about AI in Music
Learn more about AI Models

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Wellness in the Digital Era: Soaak Technologies' CEO Henry Penix Shares Insights Mar 22, 2024

Show notes

In this episode, we explore the evolving landscape of wellness through the lens of AI technology, featuring Henry Penix, CEO of Soaak Technologies, who offers insights into the company's innovative approaches and the future of personalized health solutions.

Invest in AI Box: https://Republic.com/ai-box
Get on the AI Box Waitlist: ⁠⁠https://AIBox.ai/⁠⁠
AI Facebook Community
Learn more about AI in Music
Learn more about AI Models

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

OpenAI's GDPR Gambit: Balancing Innovation and Regulation Mar 22, 2024

Show notes

In this episode, we discuss OpenAI's approach to GDPR compliance, examining the potential 4% global revenue penalty and the challenges of balancing innovation with regulatory constraints in the AI industry.